Clinical Trials Logo

Renal Cell Carcinoma Stage III clinical trials

View clinical trials related to Renal Cell Carcinoma Stage III.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT06377722 Terminated - Clinical trials for Renal Cell Carcinoma Metastatic

Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

Start date: November 1, 2018
Phase: Phase 2
Study type: Interventional

Phase II, multicenter, national, uncontrolled, multicenter, uncontrolled, phase II clinical trial for the evaluation of cabozantinib treatment prior to cytoreductive nephrectomy in patients with advanced or metastatic renal cell cancer candidates for primary tumor cytoreductive nephrectomy (NC).